Search clinical trials for: BI 207127: 16-week treatment

Total 293 results

Boehringer Ingelheim

Completed

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

Hepatitis C, Chronic

United States, Australia, Belgium, Canada, France, Germany, Greece, Italy, New Zealand, Portugal, Spain, United Kingdom
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection

Hepatitis C, Chronic

United States, Australia, Austria, France, Germany, New Zealand, Portugal, Romania, Spain, Switzerland
Boehringer Ingelheim

Completed

Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male Volunteers

Healthy

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of Different Multiple Doses of BI 207127 BID and Multiple Doses of BI 207127 Combined With Faldaprevir in Healthy Male and Female Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients

Hepatitis C, Chronic

France, Germany, Switzerland
Boehringer Ingelheim

Terminated

Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired Patients

Renal Insufficiency

Germany
Boehringer Ingelheim

Completed

Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers

Healthy

Korea, Republic of
Boehringer Ingelheim

Completed

Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male Subjects

Healthy
New Mexico VA Healthcare System

Completed

Effectiveness of Cognitive, Exposure, and Skills Group Manualized Treatments in Operations Iraqi (OIF)/Operation Enduring Freedom (OEF) Female Veterans

Post Traumatic Stress Disorder

United States
University of Birmingham
BUPA Foundation

Unknown

"Step by Step": A Feasibility Study of the Promotion of Lunchtime Walking to Increase Physical Activity and Improve Mental Well-being in Sedentary Employees

Exercise | Sedentary

United Kingdom
Boehringer Ingelheim

Terminated

Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese Subjects

Healthy

Germany
Presidio Pharmaceuticals, Inc.
Boehringer Ingelheim

Completed

Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C

Chronic Hepatitis C

United States
Wake Forest University Health Sciences

Completed

Food Addiction Clinical Treatment Program (FACT)

Food Addiction

United States
Boehringer Ingelheim

Completed

Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C]-BI 207127 in Healthy Male Volunteers

Healthy

United States
Boehringer Ingelheim

Completed

BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3

Hepatitis C, Chronic

United States, Germany, Spain, United Kingdom
Boehringer Ingelheim

Completed

Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected Patients

Hepatitis C, Chronic
Northern Orthopaedic Division, Denmark
University of Aarhus

Completed

Focus of a Running Schedule and Risk of Running Injuries

Running Related Injuries

Denmark
Denver Health and Hospital Authority
Agency for Healthcare Research and Quality (AHRQ)

Completed

Reporting Patient Generated Health Data and Patient Reported Outcomes With Health Information Technology

Obesity

United States
Boehringer Ingelheim

Completed

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Hepatitis C, Chronic

United States, Austria, Canada, France, Germany, Hungary, Ireland, Italy, Netherlands, Portugal, Romania, Russian Federation, Spain, United Kingdom
Boehringer Ingelheim

Completed

Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects.

Healthy

Germany
Boehringer Ingelheim

Completed

This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C

Hepatitis C, Chronic

Japan
Stockholm University

Active, not recruiting

The Study of Internet-delivered, Transdiagnostic Treatments for Anxiety and Depression (TRAbee)

Depression | Anxiety Disorders

Sweden
Asahi Kasei Pharma Corporation

Recruiting

Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
University of Arizona

Suspended

Type 2 Diabetes Prevention in Community Health Care Settings for at Risk Children and Mothers

PreDiabetes | Type 2 Diabetes

United States
Boehringer Ingelheim

Completed

A Study in Healthy People to Test if Taking Different Formulations of BI 425809 Tablets Influences the Amount of BI 425809 in the Blood

Healthy

Germany
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Acupuncture Pilot Study for Cancer-related Cognitive Function

Gynecologic Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage III Breast Cancer | Stage III Gynecologic Cancer | Stage III Colorectal Cancer | Stage I Colorectal Cancer | Stage II Colorectal Cancer | Stage I Gynecologic... and other conditions

United States
UNC Lineberger Comprehensive Cancer Center

Completed

Get REAL and HEEL Research Program

Breast Cancer

United States
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects

Healthy Volunteers

Germany
Association Francaise pour la Recherche Thermale
University Hospital, Grenoble; Floralis

Withdrawn

SPA Therapy in the Treatment of Sleep Apnea Syndrome (THERMA-SAS)

Obstructive Sleep Apnea Syndrome | Chronic Venous Insufficiency

France
Boehringer Ingelheim

Withdrawn

Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

Hepatitis C, Chronic

Australia, Spain, Sweden
Universidade Federal do Rio de Janeiro

Recruiting

Neuromuscular Characteristics of Strict Vegetarians and Non-Vegetarians Women

Hypertrophy

Brazil
Zai Lab (Hong Kong), Ltd.
Zai Lab (US) LLC

Not yet recruiting

A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis

Plaque Psoriasis

Australia
EVYD Technology
Raja Isteri Pengiran Anak Saleha Hospital

Completed

Development and Exploration of the Effectiveness and Feasbility of a Digital Intervention for Type 2 Diabetes Mellitus (DEsireD)

Diabetes Mellitus, Type II

Singapore
Norwegian University of Science and Technology

Completed

Periodized Resistance Training for Persistent Non-specific Low Back Pain

Low Back Pain

Norway
University of Salford
Northern Care Alliance NHS Foundation Trust

Unknown

The Role of Arthrogenic Muscular Inhibition in Patellofemoral Pain and the Response to an Exercise Programme (PFP-Inhibit)

Patellofemoral Pain | Anterior Knee Pain | PFP

United Kingdom
Stanford University
National Institute on Aging (NIA)

Completed

Hoarding Disorder Treatment With Virtual Reality (HDVR)

Hoarding Disorder | Hoarding | Clutter

United States
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B

Hepatitis B, Chronic

Taiwan
Utrecht Institute for Pharmaceutical Sciences
UCB Pharma

Terminated

Seasonal Allergic Rhinitis and Driving Ability

Seasonal Allergic Rhinitis

Netherlands
Organon and Co

Completed

A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)

Asthma
Mediprobe Research Inc.
Emblation Limited

Recruiting

Pilot Study of Swift Microwave Device for Onychomycosis

Onychomycosis of Toenail

Canada
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers

Hypertension | Dyslipidemias

Korea, Republic of
Pennington Biomedical Research Center

Completed

Effects of Exercise for Overweight Women With Polycystic Ovary Syndrome (POLY)

Obesity | Polycystic Ovary Syndrome

United States
Medical University of Graz

Completed

Image Guided Adaptive Radiotherapy in the Head-and-neck Region (BART)

Head and Neck Neoplasms
Organon and Co

Completed

Health Assessment Study (0954-946)

Hypertension
University of California, Davis
National Mango Board

Completed

Influence of Mango Intake of Skin Health in Postmenopausal Women (MSS)

Wrinkle | Skin Red

United States
University of Michigan
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

SafERteens M-Coach

Alcohol Drinking | Violence

United States
National Taiwan University Hospital
BRIDGECON CO,.LTD.

Recruiting

Efficacy of Periorbital Rejuvenation With a 1927 nm Diode Laser Treatment

Laser | Periorbital

Taiwan
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...

Recruiting

Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer (TiMiSNAR)

Rectal Cancer

Italy
University of Colorado, Denver

Recruiting

Should Graf IIc Hips be Treated for 12 Weeks

Developmental Dysplasia of Hip

United States

3

Subscribe